Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration - Business Wire
By:Business Wire
Source:Business Wire
Published:
Related News
AAPL vs. MSFT vs. TSLA: Wall Street’s Favorite Magnificent 7 Stock Ahead of Q4 Earnings Season - TipRanks
Four of the “Magnificent 7” stocks — Apple ($AAPL), Tesla ($TSLA), Microsoft ($MSFT), and Meta Platforms ($META) — are set to report earnings next week, between January 26 and January 30. Using TipRanks’
Tipranks.com•Shalu Saraf
Winter storm could knock out power for up to 200,000 Houston area customers, CenterPoint says - khou.com
CenterPoint Energy projects 100,000 to 200,000 outages across Houston area over the course of the storm.
KHOU.com•Anne James
US Winter Storm Sets Off Power Grid Emergencies, Travel Chaos - Bloomberg
A sprawling winter storm has grounded more than 14,500 flights around the US, triggered a grid emergency and knocked out power to thousands, all while threatening to drop a foot of snow on New York City and the rest of the Northeast corridor on Sunday.
Bloomberg•Brian K Sullivan, Naureen S Malik, Mary Hui